These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34321129)

  • 1. Comparing Stop Signal Reaction Times in Alzheimer's and Parkinson's Disease.
    Rahman S; Siddique U; Choudhury S; Islam N; Roy A; Basu P; Anand SS; Islam MA; Shahi MS; Nayeem A; Chowdhury MTI; Chowdhury MSJH; Taylor JP; Baker MR; Baker SN; Kumar H
    Can J Neurol Sci; 2022 Sep; 49(5):662-671. PubMed ID: 34321129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowed Movement Stopping in Parkinson's Disease and Focal Dystonia is Improved by Standard Treatment.
    Choudhury S; Roy A; Mondal B; Singh R; Halder S; Chatterjee K; Baker MR; Kumar H; Baker SN
    Sci Rep; 2019 Dec; 9(1):19504. PubMed ID: 31862983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Diazepam on Reaction Times to Stop and Go.
    Sarkar S; Choudhury S; Islam N; Chowdhury MSJH; Chowdhury MTI; Baker MR; Baker SN; Kumar H
    Front Hum Neurosci; 2020; 14():567177. PubMed ID: 33132880
    [No Abstract]   [Full Text] [Related]  

  • 4. Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease.
    Rolinski M; Griffanti L; Szewczyk-Krolikowski K; Menke RA; Wilcock GK; Filippini N; Zamboni G; Hu MT; Mackay CE
    Neuroimage Clin; 2015; 8():126-32. PubMed ID: 26106536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postural set for balance control is normal in Alzheimer's but not in Parkinson's disease.
    Chong RK; Jones CL; Horak FB
    J Gerontol A Biol Sci Med Sci; 1999 Mar; 54(3):M129-35. PubMed ID: 10191840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease.
    Wylie SA; van Wouwe NC; Godfrey SG; Bissett PG; Logan GD; Kanoff KE; Claassen DO; Neimat JS; van den Wildenberg WPM
    Neuropsychologia; 2018 Jan; 109():262-269. PubMed ID: 29269306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
    Mizutani Y; Ohdake R; Tatebe H; Higashi A; Shima S; Ueda A; Ito M; Tokuda T; Watanabe H
    J Neurol; 2023 Nov; 270(11):5461-5474. PubMed ID: 37480401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Crossman AR
    Dementia; 1993; 4(2):61-5. PubMed ID: 8358514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study.
    Ułas J; Weihmuller FB; Brunner LC; Joyce JN; Marshall JF; Cotman CW
    J Neurosci; 1994 Nov; 14(11 Pt 1):6317-24. PubMed ID: 7965038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases.
    Wang S; Zhang C; Sheng X; Zhang X; Wang B; Zhang G
    J Clin Neurosci; 2014 May; 21(5):810-4. PubMed ID: 24405770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease.
    Tadayon E; Pascual-Leone A; Press D; Santarnecchi E;
    Neurobiol Aging; 2020 May; 89():108-117. PubMed ID: 32107064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overriding actions in Parkinson's disease: Impaired stopping and changing of motor responses.
    van den Wildenberg WPM; Ridderinkhof KR; van Wouwe NC; Neimat JS; Bashore TR; Wylie SA
    Behav Neurosci; 2017 Oct; 131(5):372-84. PubMed ID: 28805433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.